New evidence-based guidelines on the management of diabetic foot infections reflect significant advances by researchers and clinicians, but the recent emergence of regulatory hurdles has slowed the development of new antibiotic drugs for treating those infections.
Read the original:
Diabetic foot infections: Progress meets pitfalls
